WASHINGTON, D.C. – Pierre Kory, M.D., president and chief medical officer of the FLCCC, will testify in the Arizona State Senate tomorrow as part of a two-day hearing, joining a delegation of physicians, scientists, and legal experts. Members of the Arizona State Legislature have invited Dr. Kory and others to discuss the significant impact the state and national pandemic response had on public health and what policy changes to consider in protecting the practice of medicine and the integrity of scientific data in the future.
In his testimony, Dr. Kory will review how corporate interests heavily influenced health policy decisions at the state level to follow federal guidance that favored the use of new and expensive treatments that were largely ineffective and often harmful. At the same time, they campaigned to ignore, demonize, and downplay less costly and well-known therapies that were already proven effective to treat COVID-19. Dr. Kory will provide details and extensive data demonstrating the efficacy and safety of ivermectin. Data that government officials refused to acknowledge or used falsely to misguide hospitals to prohibit the drug’s use, and then medical authorities felt justified to punish doctors who prescribed it for treating COVID-19.
“No one person, entity, or institution has a monopoly on good ideas. Science and medicine are constantly evolving and changing. Policymakers must keep up,” said Pierre Kory, M.D., M.P.A., president and chief medical officer of the FLCCC. “I am encouraged by the interest of the members of the Arizona legislature who will participate in discussion with us this week. I hope the conversation continues and will lead to real change to prevent the horrible policies made in response to COVID-19 from ever happening again.”
The two-day hearing will be the first before a special committee established by Arizona lawmakers to examine federal, state, and local efforts in response to the COVID-19 pandemic and identify policyand legal remedies to prevent unnecessary regulations and flawed public health guidance in the future.
More information on the delegation and a live stream of the proceedings can be found here:
About the Front Line COVID-19 Critical Care Alliance
The FLCCC Alliance was organized in March 2020 by a group of highly published, world renowned critical care physicians and scholars with the academic support of allied physicians from around the world. FLCCC’s goal is to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness including the I-RECOVER protocols for “Long COVID” and Post Vaccine Syndrome. For more information: www.FLCCC.net